Jun 06, 2019
Update on Oculopharyngeal Muscular Dystrophy Program
Feb 14, 2019
SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement to Develop and Commercialize Cenobamate in Europe
Jan 02, 2019
Roivant Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference
Sep 25, 2018
Orphan Star Therapeutics Announces Initial Financing and Corporate Update
Jul 08, 2018
Benitec Announces Global Licensing Agreement for BB-301 for Treatment of Oculopharyngeal Muscular Dystrophy and Broad Platform Collaboration with Axovant
Apr 30, 2018
Technical Perspectives on Biotech Stocks -- Axovant Sciences, Aytu BioScience, BeiGene, and Bellicum Pharma
Jan 31, 2018
This Morning's Technical Outlook on Biotech Stocks -- Arena Pharma, Arrowhead Pharma, Axovant Sciences, and Biogen
Nov 07, 2017
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2017 Financial Results
Nov 01, 2017
Stocks Under Scanner in the Biotech Space -- Axovant Sciences, Gilead Sciences, Novavax, and Opko Health
Sep 26, 2017
Axovant Announces Negative Topline Results of Intepirdine Phase 3 MINDSET Trial in Alzheimer's Disease
Sep 06, 2017
Axovant to Present at Two Upcoming Investor Conferences
Aug 21, 2017
Axovant to Move Stock Exchange Listing to Nasdaq
Aug 09, 2017
Daily Technical Summary Reports on Biotech Stocks -- Axovant Sciences, Ampio Pharma, ImmunoCellular Therapeutics, and Synthetic Biologics
Aug 07, 2017
Axovant Announces Fiscal First Quarter Financial Results and Corporate Updates
Jul 19, 2017
New Preclinical Data for Intepirdine Suggests Potential Neuroprotective Properties
Jul 10, 2017
Axovant to Present Key Intepirdine and Nelotanserin Data at Alzheimer's Association International Conference
Jun 19, 2017
FDA Grants Fast Track Designation to Axovant's Nelotanserin for Visual Hallucinations in Dementia with Lewy Bodies
Jun 13, 2017
Axovant Sciences Announces Fiscal Year-End Financial Results and Corporate Updates
Jun 06, 2017
Axovant Announces Changes to Board of Directors
Jun 06, 2017
Axovant Strengthens Executive Team with Key Management Appointments